Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 45, 2015, Pages 14048-14053

  Liu, Chien Hung ^a   Zhou, Ligang ^a   Chen, Guifang ^a   Krug, Robert M ^a  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Influenza A virus polymerase protein subunits; Poly(ADP ribosylation); Proteasomal degradation; Ubiquitination; ZAPL PARP domain

Indexed keywords

ANTIVIRUS AGENT; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN; PROTEIN PA; PROTEIN PB2; PROTEIN ZAPL; UNCLASSIFIED DRUG; VIRUS PROTEIN; COMPLEMENTARY DNA; PRIMER DNA; RNA BINDING PROTEIN; VIRAL PROTEIN; ZC3HAV1 PROTEIN, HUMAN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLUENZA A VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN INTERACTION; PROTEIN PROCESSING; UBIQUITINATION; VIRUS REPLICATION; ANIMAL; BIOLOGICAL MODEL; CELL LINE; DOG; GENETICS; IMMUNOPRECIPITATION; MDCK CELL LINE; METABOLISM; MOLECULAR CLONING; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CELL LINE; CLONING, MOLECULAR; DNA PRIMERS; DNA, COMPLEMENTARY; DOGS; HUMANS; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; MADIN DARBY CANINE KIDNEY CELLS; MODELS, BIOLOGICAL; POLY(ADP-RIBOSE) POLYMERASES; PROTEOLYSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; UBIQUITINATION; VIRAL PROTEINS;

EID: 84946962989     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1509745112     Document Type: Article

References (32)

1. Wright P, Neumann G, Kawaoka Y (2012) Orthomyxoviruses. Fields Virology, eds Knipe DM, Howley, PM (Lippincott Williams & Wilkins, Philadelphia), 6th Ed, pp 1186-1243.
2. Krug RM, Fodor E (2013) The virus genome and its replication. Influenza Textbook, ed Webster RG, Monto AS, Braciale TJ, Lamb RA (Wiley-Blackwell, Hoboken, NJ), 2nd Ed, pp 57-66.
3. Resa-Infante P, Jorba N, Coloma R, Ortin J (2011) The influenza virus RNA synthesis machine: Advances in its structure and function. RNA Biol 8(2):207-215.
4. Pflug A, Guilligay D, Reich S, Cusack S (2014) Structure of influenza A polymerase bound to the viral RNA promoter. Nature 516(7531):355-360.
5. Krug RM, Garcia-Sastre A (2013) The NS1 protein: A master regulator of host and viral functions. Influenza Textbook, eds Webster RG, Monto AS, Braciale TJ, Lamb RA (Wiley-Blackwell, Hoboken, NJ), 2nd Ed, pp 114-132.
6. Nemeroff ME, Barabino SM, Li Y, Keller W, Krug RM (1998) Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs. Mol Cell 1(7):991-1000.
7. Chen G, Liu CH, Zhou L, Krug RM (2014) Cellular DDX21 RNA helicase inhibits influenza A virus replication but is counteracted by the viral NS1 protein. Cell Host Microbe 15(4):484-493.
8. Kerns JA, Emerman M, Malik HS (2008) Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet 4(1):e21.
9. Gao G, Guo X, Goff SP (2002) Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297(5587):1703-1706.
10. Guo X, Carroll JW, Macdonald MR, Goff SP, Gao G (2004) The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J Virol 78(23):12781-12787.
11. Guo X, Ma J, Sun J, Gao G (2007) The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc Natl Acad Sci USA 104(1): 151-156.
12. Bick MJ, et al. (2003) Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J Virol 77(21):11555-11562.
13. Müller S, et al. (2007) Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol 81(5):2391-2400.
14. Zhu Y, et al. (2011) Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc Natl Acad Sci USA 108(38):15834-15839.
15. Kleine H, et al. (2008) Substrate-assisted catalysis by PARP10 limits its activity to mono-ADP-ribosylation. Mol Cell 32(1):57-69.
16. Charron G, Li MM, MacDonald MR, Hang HC (2013) Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP longisoform. Proc Natl Acad Sci USA 110(27):11085-11090.
17. Gläsker S, Töller M, Kümmerer BM (2014) The alternate triad motif of the poly(ADP-ribose) polymerase-like domain of the human zinc finger antiviral protein is essential for its antiviral activity. J Gen Virol 95(Pt 4):816-822.
18. Wang Z, et al. (2012) Recognition of the iso-ADP-ribose moiety in poly(ADP-ribose) by WWE domains suggests a general mechanism for poly(ADP-ribosyl)ation-dependent ubiquitination. Genes Dev 26(3):235-240.
19. Leung AK, et al. (2011) Poly(ADP-ribose) regulates stress responses and microRNA activity in the cytoplasm. Mol Cell 42(4):489-499.
20. Fodor E, Smith M (2004) The PA subunit is required for efficient nuclear accumulation of the PB1 subunit of the influenza A virus RNA polymerase complex. J Virol 78(17): 9144-9153.
21. Zhang Y, et al. (2011) RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling. Nat Cell Biol 13(5):623-629.
22. DaRosa PA, et al. (2015) Allosteric activation of the RNF146 ubiquitin ligase by a poly (ADP-ribosyl)ation signal. Nature 517(7533):223-226.
23. Meyer-Ficca ML, Meyer RG, Coyle DL, Jacobson EL, Jacobson MK (2004) Human poly (ADP-ribose) glycohydrolase is expressed in alternative splice variants yielding iso-forms that localize to different cell compartments. Exp Cell Res 297(2):521-532.
24. Guettler S, et al. (2011) Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease. Cell 147(6):1340-1354.
25. Twu KY, Noah DL, Rao P, Kuo RL, Krug RM (2006) The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target. J Virol 80(8): 3957-3965.
26. Zhao C, Denison C, Huibregtse JM, Gygi S, Krug RM (2005) Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci USA 102(29):10200-10205.
27. Ochoa M, et al. (1995) Epitope mapping of cross-reactive monoclonal antibodies specific for the influenza A virus PA and PB2 polypeptides. Virus Res 37(3):305-315.
28. Chen BJ, Leser GP, Morita E, Lamb RA (2007) Influenza virus hemagglutinin and neuraminidase, but not the matrix protein, are required for assembly and budding of plasmid-derived virus-like particles. J Virol 81(13):7111-7123.
29. Naldini L, et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272(5259):263-267.
30. Levaot N, et al. (2011) Loss of Tankyrase-mediated destruction of 3BP2 is the underlying pathogenic mechanism of cherubism. Cell 147(6):1324-1339.
31. Seo GJ, et al. (2013) Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host Microbe 14(4):435-445.
32. Söderberg O, et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3(12):995-1000.